🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📱 New research co-authored by GCDTR members analyzes 30,475 six-minute walk tests via the My Heart Counts app—the largest dataset of its kind! Findings validate key health associations & show app use improves functional capacity. sciencedirect.com/science/articl…

New study reveals the advantages of hybrid closed-loop (HCL) insulin therapy for postpartum women with type 1 diabetes! 🤰Study finds HCL users had 70% time in range postpartum—far higher than standard insulin therapy. doi.org/10.1016/s2213-…

Meet EGDRC's Zhongyu Li! 🌍🔬 A PhD student in Nutrition & Health Sciences at Emory University, passionate about chronic disease prevention & global health research. Currently supported by @Emory_LGS funds, she’s making an impact! 🔗diabetes.emory.edu/news/meet-zhon…

Islet Transplantation vs. Standard Care for T1D & Severe Hypoglycemia 🔗 doi.org/10.2337/dc24-1… ✅ Better control (HbA1c <7%): 71-80% vs. 21-33% ✅ Fewer severe hypos ⚠️ Greater kidney decline 🔬 5-year CITR vs. T1DX study

Despite declines in age-standardized rates, the absolute number of stroke cases & deaths increased across 38 countries. Alarmingly, ischemic stroke mortality & DALY rates are rising among younger adults. ✏️ Co-author: Rodrigo M. Carrillo-Larco 🔗 doi.org/10.1016/j.lana…

Can HIIT help prevent type 2 diabetes in those with isolated impaired fasting glucose (i-IFG)? EGDRC's Sathish Thirunavukkarasu is leading a study to test the feasibility & effectiveness of an 8-week HIIT intervention. Recruitment starts Feb 2025! LEARN MORE: 🔗pubmed.ncbi.nlm.nih.gov/39977858/

📢 Congratulations to EGDRC's Dr. K.M. Venkat Narayan on receiving the 2025 Distinguished International Service in the Cause of Diabetes award from American Diabetes Association! His global impact on diabetes research & prevention is truly inspiring. 🔗 diabetes.org/newsroom/press…

📢 Congratulations to Dr. Liliana Aguayo for receiving the Mark Bieber Award at the 2025 American Heart Association Epi-Lifestyle meeting! This award recognizes outstanding early-career nutrition research & honors Dr. Mark Bieber’s contributions to nutritional science. professional.heart.org/en/meetings/ep…

🚀 Ready to tackle diabetes challenges in India? Join @EmoryGlobalDiab, @GT_IPaT & IIT Madras for a virtual hackathon! Collaborate, innovate & compete for cash prizes! Open to students from IIT Madras, GT, Emory, AIIMS Delhi, CMC Vellore & JIPMER. dt10x-india.devpost.com

Diabetes tech in hospitals is evolving! A new Emory-led review highlights the growing role of continuous glucose monitoring (CGM) & automated insulin delivery (AID) for inpatient care. Can these tools improve diabetes management in hospitals? 🔗 liebertpub.com/doi/10.1089/di…

📢 New findings from the INHALE-3 Extension Study! Inhaled technosphere insulin (TI) + insulin degludec sustained improved HbA1c levels over 30 weeks in adults with type 1 diabetes. 42% reached A1C <7.0% by week 30! 🔗 doi.org/10.1089/dia.20…

New study in Diabetes Care co-authored by EGDRC's Dr. Guillermo Umpierrez finds ~24% of people with difficult-to-control type 2 diabetes may have hypercortisolism—potentially contributing to poor glycemic control despite multiple meds. doi.org/10.2337/dc24-2…

With this year’s numbers still rolling in, we’re celebrating a big win from last year: 1,343 publications! 🎉 Huge kudos to the entire #EGDRC team—core researchers, affiliates, postdocs, and fellows—for driving impactful science. Explore our annual report: diabetes.emory.edu/2023-2024-annu…

"Facts alone don’t change minds—but connection can." EGDRC Director, K.M. Venkat Narayan shares how humility, dialogue, and storytelling can strengthen science and public health in a new NAM member spotlight. Read more: nam.edu/news-and-insig… #PublicHealth #NAMNewsroom

📢 New study: Sexual minority couples show high concordance in hypertension & overweight/obesity — especially among male couples. Findings highlight the need for couple-level interventions to reduce shared cardiometabolic risk.🔗 doi.org/10.1016/j.anne…

Dr. Carl Yang is using AI to personalize #diabetes care. His TACCO #algorithm clusters patients by shared risk factors—clinical, behavioral & genetic—for better outcomes. Learn how #EGDRC fosters the collaboration to make this possible. #DiabetesResearch 📎diabetes.emory.edu/news/bridging-…

🆕 A must-read in Preventing Chronic Disease: “Harnessing the Power of #CommunityEngagement for Population Health” by GCDTR member Tabia Henry Akintobi (Morehouse School of Medicine) spotlights trust & community-led public health. doi.org/10.5888/pcd22.… PC&D Journal

📢 A new Emory-led study published in The Lancet Diabetes & Endocrinology by Dr.Guillermo Umpierrez & Dr. Thaer Idrees explores the evolution of fixed-ratio insulin–GLP-1 RA therapies like IcoSema for type 2 diabetes care. thelancet.com/journals/landi… #Diabetes #GLP1 #Insulin #EGDRC

📈 New Emory-led study links higher arterial stiffness (pulse wave velocity) to increased odds of #Alzheimers biomarker positivity. Non-invasive PWV could signal early AD risk. 🔗 doi.org/10.1177/138728… #Neurology #EGDRC #BrainHealth

📢 New in Diabetes Care: CGM metrics moderately correlate w/ stimulated C-peptide in youth w/ new-onset T1D, but not strong enough to replace C-peptide in trials. Co-author: GCDTR's Roy W. Beck (Jaeb Center for Health Research)🔗 doi.org/10.2337/dc25-0… #T1D #CGM #DiabetesResearch #DiabetesCare